vs
Side-by-side financial comparison of Commerce.com, Inc. (CMRC) and RHYTHM PHARMACEUTICALS, INC. (RYTM). Click either name above to swap in a different company.
Commerce.com, Inc. is the larger business by last-quarter revenue ($89.5M vs $57.3M, roughly 1.6× RHYTHM PHARMACEUTICALS, INC.). Commerce.com, Inc. runs the higher net margin — -9.3% vs -83.0%, a 73.6% gap on every dollar of revenue. On growth, RHYTHM PHARMACEUTICALS, INC. posted the faster year-over-year revenue change (36.9% vs 2.9%). Over the past eight quarters, RHYTHM PHARMACEUTICALS, INC.'s revenue compounded faster (48.5% CAGR vs 5.5%).
SPS Commerce, Inc. is a technology and application software company based in the United States that provides cloud-based supply chain management software. The company's headquarters are located in Minneapolis, Minnesota, but it also has a US office in New Jersey, and international locations in Amsterdam, Beijing, Breukelen, Hong Kong, Kyiv, Melbourne, Montpellier, Sydney, and Toronto.
Rhythm Pharmaceuticals is a biopharmaceutical firm focused on developing and commercializing targeted therapies for rare genetic disorders causing severe unmanageable obesity, including POMC deficiency, LEPR deficiency, and Bardet-Biedl syndrome. It serves patients in North America and Europe who lack effective standard treatments for their chronic life-altering conditions.
CMRC vs RYTM — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $89.5M | $57.3M |
| Net Profit | $-8.4M | $-47.5M |
| Gross Margin | 78.3% | 91.6% |
| Operating Margin | -7.4% | -82.2% |
| Net Margin | -9.3% | -83.0% |
| Revenue YoY | 2.9% | 36.9% |
| Net Profit YoY | -250.0% | -9.6% |
| EPS (diluted) | $-0.11 | $-0.73 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $89.5M | $57.3M | ||
| Q3 25 | $86.0M | $51.3M | ||
| Q2 25 | $84.4M | $48.5M | ||
| Q1 25 | $82.4M | $32.7M | ||
| Q4 24 | $87.0M | $41.8M | ||
| Q3 24 | $83.7M | $33.3M | ||
| Q2 24 | $81.8M | $29.1M | ||
| Q1 24 | $80.4M | $26.0M |
| Q4 25 | $-8.4M | $-47.5M | ||
| Q3 25 | $-2.2M | $-52.9M | ||
| Q2 25 | $-8.4M | $-46.6M | ||
| Q1 25 | $-353.0K | $-49.5M | ||
| Q4 24 | $-2.4M | $-43.3M | ||
| Q3 24 | $-7.0M | $-43.6M | ||
| Q2 24 | $-11.3M | $-32.3M | ||
| Q1 24 | $-6.4M | $-141.4M |
| Q4 25 | 78.3% | 91.6% | ||
| Q3 25 | 78.4% | 89.3% | ||
| Q2 25 | 79.0% | 88.6% | ||
| Q1 25 | 79.4% | 88.8% | ||
| Q4 24 | 77.6% | 90.9% | ||
| Q3 24 | 76.3% | 88.5% | ||
| Q2 24 | 75.8% | 89.9% | ||
| Q1 24 | 77.1% | 89.2% |
| Q4 25 | -7.4% | -82.2% | ||
| Q3 25 | -0.5% | -102.6% | ||
| Q2 25 | -8.0% | -93.4% | ||
| Q1 25 | -2.9% | -143.7% | ||
| Q4 24 | -0.9% | -98.6% | ||
| Q3 24 | -23.0% | -132.0% | ||
| Q2 24 | -16.5% | -139.2% | ||
| Q1 24 | -10.2% | -538.7% |
| Q4 25 | -9.3% | -83.0% | ||
| Q3 25 | -2.6% | -103.1% | ||
| Q2 25 | -9.9% | -96.1% | ||
| Q1 25 | -0.4% | -151.4% | ||
| Q4 24 | -2.7% | -103.6% | ||
| Q3 24 | -8.4% | -131.2% | ||
| Q2 24 | -13.8% | -110.9% | ||
| Q1 24 | -8.0% | -544.4% |
| Q4 25 | $-0.11 | $-0.73 | ||
| Q3 25 | $-0.03 | $-0.82 | ||
| Q2 25 | $-0.10 | $-0.75 | ||
| Q1 25 | $0.00 | $-0.81 | ||
| Q4 24 | $-0.03 | $-0.71 | ||
| Q3 24 | $-0.09 | $-0.73 | ||
| Q2 24 | $-0.15 | $-0.55 | ||
| Q1 24 | $-0.08 | $-2.35 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $141.1M | $388.9M |
| Total DebtLower is stronger | $157.0M | — |
| Stockholders' EquityBook value | $39.4M | $139.1M |
| Total Assets | $308.8M | $480.2M |
| Debt / EquityLower = less leverage | 3.99× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $141.1M | $388.9M | ||
| Q3 25 | $142.0M | $416.1M | ||
| Q2 25 | $134.5M | $291.0M | ||
| Q1 25 | $120.7M | $314.5M | ||
| Q4 24 | $178.2M | $320.6M | ||
| Q3 24 | $168.4M | $298.4M | ||
| Q2 24 | $275.8M | $319.1M | ||
| Q1 24 | $265.2M | $201.2M |
| Q4 25 | $157.0M | — | ||
| Q3 25 | $157.3M | — | ||
| Q2 25 | $157.5M | — | ||
| Q1 25 | $157.8M | — | ||
| Q4 24 | $216.5M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $340.9M | — | ||
| Q1 24 | $340.5M | — |
| Q4 25 | $39.4M | $139.1M | ||
| Q3 25 | $42.8M | $148.8M | ||
| Q2 25 | $38.8M | $-11.9M | ||
| Q1 25 | $38.1M | $18.9M | ||
| Q4 24 | $33.4M | $21.7M | ||
| Q3 24 | $29.0M | $11.2M | ||
| Q2 24 | $26.1M | $39.3M | ||
| Q1 24 | $26.9M | $61.6M |
| Q4 25 | $308.8M | $480.2M | ||
| Q3 25 | $309.5M | $506.9M | ||
| Q2 25 | $302.5M | $372.7M | ||
| Q1 25 | $286.3M | $386.7M | ||
| Q4 24 | $340.3M | $392.3M | ||
| Q3 24 | $335.1M | $363.6M | ||
| Q2 24 | $452.5M | $381.8M | ||
| Q1 24 | $442.5M | $258.7M |
| Q4 25 | 3.99× | — | ||
| Q3 25 | 3.67× | — | ||
| Q2 25 | 4.06× | — | ||
| Q1 25 | 4.14× | — | ||
| Q4 24 | 6.49× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 13.06× | — | ||
| Q1 24 | 12.65× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $980.0K | $-25.4M |
| Free Cash FlowOCF − Capex | $-2.2M | — |
| FCF MarginFCF / Revenue | -2.4% | — |
| Capex IntensityCapex / Revenue | 3.5% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $16.9M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $980.0K | $-25.4M | ||
| Q3 25 | $10.6M | $-26.6M | ||
| Q2 25 | $13.6M | $-23.3M | ||
| Q1 25 | $401.0K | $-40.4M | ||
| Q4 24 | $12.4M | $-18.8M | ||
| Q3 24 | $5.6M | $-25.2M | ||
| Q2 24 | $11.7M | $-29.1M | ||
| Q1 24 | $-3.4M | $-40.7M |
| Q4 25 | $-2.2M | — | ||
| Q3 25 | $7.6M | — | ||
| Q2 25 | $11.9M | — | ||
| Q1 25 | $-424.0K | — | ||
| Q4 24 | $11.6M | — | ||
| Q3 24 | $4.5M | — | ||
| Q2 24 | $10.7M | — | ||
| Q1 24 | $-4.2M | — |
| Q4 25 | -2.4% | — | ||
| Q3 25 | 8.8% | — | ||
| Q2 25 | 14.1% | — | ||
| Q1 25 | -0.5% | — | ||
| Q4 24 | 13.3% | — | ||
| Q3 24 | 5.4% | — | ||
| Q2 24 | 13.0% | — | ||
| Q1 24 | -5.3% | — |
| Q4 25 | 3.5% | — | ||
| Q3 25 | 3.4% | — | ||
| Q2 25 | 2.0% | — | ||
| Q1 25 | 1.0% | — | ||
| Q4 24 | 0.9% | — | ||
| Q3 24 | 1.3% | — | ||
| Q2 24 | 1.3% | — | ||
| Q1 24 | 1.0% | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CMRC
| Subscription And Circulation | $65.2M | 73% |
| Partner And Services | $24.4M | 27% |
RYTM
Segment breakdown not available.
